Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentric Pragmatic Randomized Controled Trial to Evaluate the Efficacy Chloroquine or Hydroxychloroquine for Five Days in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19

NCT04420247 is registered in ClinicalTrials.gov with Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva as lead sponsor.

NCT NCT04420247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04420247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentric Pragmatic Randomized Controled Trial to Evaluate the Efficacy Chloroquine or Hydroxychloroquine for Five Days in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19
Lead sponsor
Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva
Phase
Phase 3
Overall status
Completed
Start date
April 16, 2020
Completion date
September 3, 2020
Enrollment
142 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, coronavirus, covid, covid-19, sars-cov 2